Investing inAutoimmuneBreakthroughs.
Vie Ventures combines specialist biotechnology investing, immunology expertise, and disease-focused communities to advance the next generation of therapies.
The Vie advantage
Specialist investment discipline
We invest in biotechnology companies developing innovative therapies, applying rigorous scientific underwriting, venture experience, and financing discipline.
Biology across diseases
Shared immune pathways create opportunities to pursue promising therapeutic mechanisms across autoimmune and immune-mediated diseases.
Connected disease communities
Independent Strategic Collaborators contribute disease-specific expertise, patient perspective, and networks that can strengthen investment insight and development.
Vie Ventures in motion
On LinkedIn
Follow Vie Ventures →Vie Impact
Vie Impact brings biotechnology leaders and families together around a cross-autoimmune investment strategy. Participants can invest existing charitable capital or invest privately with the intention of creating pools of capital for future philanthropy. Private-return pathways are also available.
Explore Vie ImpactLatest news
See all news →Vie Ventures at FASI-10 Summit: Challenges and Opportunities in Food Allergy Drug Development
Vie VenturesOct 24, 2026
Luke Evnin at Cool Comedy • Hot Cuisine
Vie VenturesOct 13, 2026
Boom Times For Autoimmune Disease Therapies
ForbesJul 8, 2026
Food Allergy Science Initiative and Vie Ventures Announce Strategic Collaboration to Accelerate Progress Toward a Cure for Food Allergies
Business WireJun 23, 2026
Vie Ventures Looks To Fill Autoimmune Disease Funding Gap
In VivoMay 19, 2026
20 Voices: What Does 2026 Hold For Biopharma?
In VivoFeb 23, 2026
Building the future of autoimmune therapeutics.
Whether you are a prospective investor, a strategic collaborator, or a company creating next-generation therapies, we would be glad to connect.
Or email us directly at contact@vieventures.com.